Chemical Compound Review:
Efaroxan 2-(2-ethyl-3H-benzofuran-2- yl)-4,5-dihydro...
Synonyms:
Efaroxano, Efaroxanum, CHEMBL57895, SureCN127096, BSPBio_003306, ...
- Relative importance of medullary brain nuclei for the sympatho-inhibitory actions of rilmenidine in the anaesthetized rabbit. Head, G.A., Burke, S.L. J. Hypertens. (1998)
- Interleukin (IL)-1beta toxicity to islet beta cells: Efaroxan exerts a complete protection. Papaccio, G., Graziano, A., Valiante, S., D'Aquino, R., Travali, S., Nicoletti, F. J. Cell. Physiol. (2005)
- Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine. Chan, C.K., Head, G.A. J. Hypertens. (1996)
- Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy. Rascol, O., Sieradzan, K., Peyro-Saint-Paul, H., Thalamas, C., Brefel-Courbon, C., Senard, J.M., Ladure, P., Montastruc, J.L., Lees, A. Mov. Disord. (1998)
- Identification of the central imidazoline receptor subtype involved in modulation of halothane-epinephrine arrhythmias in rats. Kagawa, K., Hayashi, Y., Itoh, I., Iwasaki, M., Takada, K., Kamibayashi, T., Yamatodani, A., Mashimo, T. Anesth. Analg. (2005)
- Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-Sensitive K+ channel-blocking compounds. Bleck, C., Wienbergen, A., Rustenbeck, I. Diabetes (2004)
- Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan. Chan, S.L., Mourtada, M., Morgan, N.G. Diabetes (2001)
- ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Chapman, J.C., McClenaghan, N.H., Cosgrove, K.E., Hashmi, M.N., Shepherd, R.M., Giesberts, A.N., White, S.J., Ammälä, C., Flatt, P.R., Dunne, M.J. Diabetes (1999)
- Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R. Bleck, C., Wienbergen, A., Rustenbeck, I. Diabetologia (2005)
- Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. Chan, C.K., Sannajust, F., Head, G.A. J. Pharmacol. Exp. Ther. (1996)
- Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs. Mest, H.J., Thomsen, P., Raap, A. Ann. N. Y. Acad. Sci. (1995)
- Potential role of imidazoline (I1) receptors in modulating aqueous humor dynamics. Campbell, W.R., Potter, D.E. Journal of ocular pharmacology. (1994)
- Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits. Parkin, M.L., Godwin, S.J., Head, G.A. J. Hypertens. (2003)
- Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: evidence for the existence of a novel imidazoline site in beta cells. Le Brigand, L., Virsolvy, A., Peyrollier, K., Manechez, D., Godfroid, J.J., Guardiola-Lemaître, B., Bataille, D. Br. J. Pharmacol. (1997)
- Induced desensitization of the insulinotropic effects of antidiabetic drugs, BTS 67 582 and tolbutamide. McClenaghan, N.H., Ball, A.J., Flatt, P.R. Br. J. Pharmacol. (2000)
- Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors. Ogidigben, M.J., Chu, T.C., Potter, D.E. Exp. Eye Res. (2001)
- Effects of imidazolines and derivatives on insulin secretion and vascular resistance in perfused rat pancreas. Berdeu, D., Gross, R., Ribes, G., Loubatières-Mariani, M.M., Bertrand, G. Eur. J. Pharmacol. (1994)
- Evidence for the existence of imidazoline-specific binding sites in synaptosomal plasma membranes of the bovine brainstem. Heemskerk, F.M., Dontenwill, M., Greney, H., Vonthron, C., Bousquet, P. J. Neurochem. (1998)
- Antagonism of the insulinotropic action of first generation imidazolines by openers of K(ATP) channels. Wienbergen, A., Bleck, C., Lackmann, T.G., Rustenbeck, I. Biochem. Pharmacol. (2007)
- Determination of underivatised efaroxan and idazoxan in blood plasma by capillary gas chromatography with mass-selective detection. Nichols, J.D., Hyde, N.A., Sugden, K. The Analyst. (1989)
- I1-imidazoline receptors and cholinergic outflow to the airways. Haxhiu, M.A., Dreshaj, I.A., McFadden, C.B., Erokwu, B.O., Ernsberger, P. J. Auton. Nerv. Syst. (1998)
- The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK). Edwards, L., Fishman, D., Horowitz, P., Bourbon, N., Kester, M., Ernsberger, P. J. Neurochem. (2001)
- Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080. Brown, C.A., Chan, S.L., Stillings, M.R., Smith, S.A., Morgan, N.G. Br. J. Pharmacol. (1993)
- Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice. Fairbanks, C.A., Wilcox, G.L. J. Pharmacol. Exp. Ther. (1999)
- The I(1)-imidazoline receptor in PC12 pheochromocytoma cells reverses NGF-induced ERK activation and induces MKP-2 phosphatase. Edwards, L., Ernsberger, P. Brain Res. (2003)
- Identification of the monomeric G-protein, Rhes, as an efaroxan-regulated protein in the pancreatic beta-cell. Chan, S.L., Monks, L.K., Gao, H., Deaville, P., Morgan, N.G. Br. J. Pharmacol. (2002)
- Involvement of phosphatidylcholine-selective phospholipase C in activation of mitogen-activated protein kinase pathways in imidazoline receptor antisera-selected protein. Li, F., Wu, N., Su, R.B., Zheng, J.Q., Xu, B., Lu, X.Q., Cong, B., Li, J. J. Cell. Biochem. (2006)
- Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy. Cao, C., Kang, C.W., Kim, S.Z., Kim, S.H. Am. J. Physiol. Heart Circ. Physiol. (2004)
- [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor. Wainscott, D.B., Sasso, D.A., Kursar, J.D., Baez, M., Lucaites, V.L., Nelson, D.L. Naunyn Schmiedebergs Arch. Pharmacol. (1998)
- Affinity isolation of imidazoline binding proteins from rat brain using 5-amino-efaroxan as a ligand. Monks, L.K., Cosgrove, K.E., Dunne, M.J., Ramsden, C.A., Morgan, N.G., Chan, S.L. FEBS Lett. (1999)
- Stimulatory effect of harmane and other beta-carbolines on locus coeruleus neurons in anaesthetized rats. Ruiz-Durántez, E., Ruiz-Ortega JA, n.u.l.l., Pineda, J., Ugedo, L. Neurosci. Lett. (2001)
- Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla. Haxhiu, M.A., Dreshaj, I., Schäfer, S.G., Ernsberger, P. J. Cardiovasc. Pharmacol. (1994)
- Sensitivity improvement of circular dichroism detection in HPLC by using a low-pass electronic noise filter: Application to the enantiomeric determination purity of a basic drug. Lorin, M., Delepee, R., Maurizot, J.C., Ribet, J.P., Morin, P. Chirality (2007)